NYMOX PHARMACEUTICAL CORPORATION Issue Of Convertible Instruments
NYMOX PHARMACEUTICAL CORPORATION (NYMXF) reported Issue Of Convertible Instruments of $1.08 million for the 12-month period ending 2017-12-31, per its 20-F filed 2020-03-30.
Discontinued › Notes
ifrs-full:IssueOfConvertibleInstruments · last filed 2020-03-30
| Period end | Issue Of Convertible Instruments 12 month |
|---|---|
| 2017-12-31 | $1.08M 20-F · filed 2020-03-30 |